Vincent Medical Holdings Limited (“Vincent Medical” or together with its subsidiaries, the “Group”; stock code: 1612) has announced its first audited annual results for the year ended 31 December 2016 (the “Year”) since its listing on the Main Board of The Stock Exchange of Hong Kong Limited on 13 July 2016.
The Group recorded a turnover of HK$467.3 million, representing a growth of 4.3%, attributable from the increase in sales of OEM imaging disposable products and the OBM products. Gross profit rose by 4.3% to HK$145.8 million, while gross profit margin was maintained at 31.2%. Adjusted profit attributable to owners of the Company increased by 5.5% to HK$55.5 million and adjusted basic earnings per share2 were 10.01 HK cents.
As at 31 December 2016, the Group was in a sound financial position with bank and cash balances amounting to HK$222.2 million (31 December 2015: HK$69.3 million). To reward shareholders for their continuous support, the Board recommended a final dividend of 1.50 HK cents per share, representing a healthy dividend payout of 32.7%.